Benelux Price Negotiations: Beware of EU-Wide Pricing Policy, warns Germany
This article was originally published in Scrip
Manufacturers could find themselves talking with multiple EU member states at once to get their orphan drugs to patients if a pilot on joint pricing negotiations is a success. Currently Belgium, the Netherlands and Luxemburg are developing the pilot, but more countries are looking at whether they may want to join in.
Register for our free email digests: